Solid Biosciences Statistics
Total Valuation
SLDB has a market cap or net worth of $780.24 million. The enterprise value is $610.60 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SLDB has 98.39 million shares outstanding. The number of shares has increased by 114.38% in one year.
| Current Share Class | 98.39M |
| Shares Outstanding | 98.39M |
| Shares Change (YoY) | +114.38% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 48.08% |
| Float | 63.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.40 |
| P/TBV Ratio | 4.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.14, with a Debt / Equity ratio of 0.12.
| Current Ratio | 6.14 |
| Quick Ratio | 5.61 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -109.90% and return on invested capital (ROIC) is -61.78%.
| Return on Equity (ROE) | -109.90% |
| Return on Assets (ROA) | -53.18% |
| Return on Invested Capital (ROIC) | -61.78% |
| Return on Capital Employed (ROCE) | -90.02% |
| Weighted Average Cost of Capital (WACC) | 17.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.44M |
| Employee Count | 121 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +168.37% in the last 52 weeks. The beta is 2.58, so SLDB's price volatility has been higher than the market average.
| Beta (5Y) | 2.58 |
| 52-Week Price Change | +168.37% |
| 50-Day Moving Average | 6.77 |
| 200-Day Moving Average | 5.90 |
| Relative Strength Index (RSI) | 58.95 |
| Average Volume (20 Days) | 1,316,082 |
Short Selling Information
The latest short interest is 9.75 million, so 9.91% of the outstanding shares have been sold short.
| Short Interest | 9.75M |
| Short Previous Month | 9.54M |
| Short % of Shares Out | 9.91% |
| Short % of Float | 15.47% |
| Short Ratio (days to cover) | 5.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -179.21M |
| Pretax Income | -174.33M |
| Net Income | -174.33M |
| EBITDA | -177.57M |
| EBIT | -179.21M |
| Earnings Per Share (EPS) | -$1.99 |
Full Income StatementBalance Sheet
The company has $187.85 million in cash and $21.16 million in debt, with a net cash position of $166.69 million or $1.69 per share.
| Cash & Cash Equivalents | 187.85M |
| Total Debt | 21.16M |
| Net Cash | 166.69M |
| Net Cash Per Share | $1.69 |
| Equity (Book Value) | 180.01M |
| Book Value Per Share | 2.28 |
| Working Capital | 171.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$156.29 million and capital expenditures -$1.15 million, giving a free cash flow of -$157.44 million.
| Operating Cash Flow | -156.29M |
| Capital Expenditures | -1.15M |
| Depreciation & Amortization | 1.64M |
| Net Borrowing | -723,000 |
| Free Cash Flow | -157.44M |
| FCF Per Share | -$1.60 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -114.38% |
| Shareholder Yield | -114.38% |
| Earnings Yield | -22.43% |
| FCF Yield | -20.26% |
Analyst Forecast
The average price target for SLDB is $16.36, which is 106.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.36 |
| Price Target Difference | 106.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 28, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Oct 28, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
